<DOC>
	<DOC>NCT00773058</DOC>
	<brief_summary>The purpose of this study is to see if stress doses of hydrocortisone improve early outcome in patients who are in early stage of ARDS and with relative adrenal insufficiency.</brief_summary>
	<brief_title>Effect of Treatment With Stress-Doses Glucocorticoid in Patients With Acute Respiratory Distress Syndrome (ARDS)</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Adrenal Insufficiency</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>within the first 3 days of onset of clinically definite ARDS confirmed by AECC criteria in 1994 18 to 85 year old pregnancy or lactation tumor or other immunologic disease immunosuppressive drug used bone marrow or lung transplantation primary or secondary disease of adrenal gland hormone used within 3 months refusing conventional therapy be in other clinical tests within 30 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>acute respiratory distress syndrome</keyword>
	<keyword>glucocorticoid</keyword>
	<keyword>adrenal insufficiency</keyword>
</DOC>